MeSH D000744 - hemolytic anemia autoimmune
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Cyclophosphamide | Neosar |  | 1993-04-29 |  |  |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| Dr Reddys Laboratories | Cyclophosphamide | Cyclophosphamide | 2036-02-15 | 2020-07-30 |  |  |
| Prednisone | Prednisone |  | 2025-10-01 |  |  | |
| Mylan | Prednisone | Prednisone |  | 1982-01-01 |  |  |
| Cipla | Cyclophosphamide | Cyclophosphamide |  | 2019-01-18 |  |  |
| AiPing Pharmaceutical | Prednisone | Prednisone |  | 1982-01-01 |  |  |
| Sanofi | Sutimlimab | Enjaymo |  | 2022-11-15 |  |  |
| Bausch Health Companies | Prednisone | Prednisone |  | 1982-01-01 |  |  |
| Merck & Co | Prednisone | Meticorten |  | 1982-01-01 |  |  |
| Bayer | Prednisone | Deltome |  | 1982-01-01 |  |  |
| Pfizer | Prednisone | Paracort |  | 1982-01-01 |  |  |
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
100%4/4
Phase 2
24%6/25
Phase 3
14%2/14
Approved: 2Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use